IRCT20180930041189N1已完成未知
Assessing serum fibrinogen and fibrin degradation products (FDP) changes in hypothermia and normothermia in patients undergoing cardiopulmonary bypass
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25 years 至 85 years（—）
- 性别
- All
入选标准
- •All adult patients undergoing heart surgery
- •Patients between 25 and 85 years
排除标准
- •History of thrombosis
- •regular aspirin use in the past 5 days
- •congenital fibrinogen disorders
- •liver disease
- •disorders or coagulation deficiencies
- •genetic disorders such as hemophilia
- •chronic renal failure patients
- •people with substance abuse
研究者
相似试验
已完成
不适用
Assesment of changes of coagulatory/ fibrinolysis factors after major hepatectomy or pancreatoduodenectomyBiliary tract carcinoma Hepatocellular carcinoma Pancreas cancerJPRN-UMIN000006642agoya university Graduate School of Medicine80
尚未招募
3 期
investigate efficacy of fibrinogen blood level correction and bleeding valume in traumatic brain injuryintra cranial bleeding in traumatic brain injury.Intracranial injuryIRCT20190129042541N1vice chancellor of research . shiraz university of medical sciences30
已完成
不适用
Fibrinolysis and bleeding tendency in the patients with severe trauma.JPRN-UMIN000003110Emergency and Critical Care, Hokkaido University Hospital50
进行中（未招募）
不适用
REPLACE (Randomized evaluation of fibrinogen versus placeboin complex cardiovascular surgery): a prospective, multinational,multicenter, randomized, double-blind, placebo-controlled, phaseIII study for the use of Fibrinogen Concentrate (Human) (FCH) incomplex cardiovascular surgeryAcute bleeding while undergoing aortic replacement surgeryMedDRA version: 14.1Level: LLTClassification code 10049052Term: Aortic surgery NOSSystem Organ Class: 100000004865EUCTR2011-002685-20-PLCSL Behring GmbH152
进行中（未招募）
不适用
REPLACE (Randomized evaluation of fibrinogen versus placeboin complex cardiovascular surgery): a prospective, multinational,multicenter, randomized, double-blind, placebo-controlled, phaseIII study for the use of Fibrinogen Concentrate (Human) (FCH) incomplex cardiovascular surgeryAcute bleeding while undergoing aortic replacement surgeryMedDRA version: 14.1Level: LLTClassification code 10049052Term: Aortic surgery NOSSystem Organ Class: 100000004865EUCTR2011-002685-20-FICSL Behring GmbH152